Precision Biosciences Inc. (DTIL)
NASDAQ · Healthcare
Precision Biosciences Inc. Shareholder Equity 2018–2025
Precision Biosciences Inc. annual shareholder equity history from 2018 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Precision Biosciences Inc. shareholder equity as of December 31, 2025: 92.2M, a 63.58% increase year-over-year.
- Precision Biosciences Inc. shareholder equity for 2025 were 92.2M, a 63.58% increase from 2024.
- Precision Biosciences Inc. shareholder equity for 2024 were 56.4M, a 198.99% increase from 2023.
- Precision Biosciences Inc. shareholder equity for 2023 were 18.9M, a 68.79% decrease from 2022.
- Precision Biosciences Inc. shareholder equity for 2022 were 60.4M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Precision Biosciences Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $92 |
| 2024 | $56 |
| 2023 | $19 |
| 2022 | $60 |
| 2021 | $91 |
| 2020 | $44 |
| 2019 | $138 |
| 2018 | $40 |
Precision Biosciences Inc. Shareholder Equity — FAQ
Precision Biosciences Inc. (DTIL) shareholder equity over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see DTIL's shareholder equity history?
The chart and table above show Precision Biosciences Inc.'s shareholder equity by year and by quarter, including the growth rate.